Data Streaming Genie Is Out Of The Bottle, Confluent Positioned To Capitalize: Analyst
Needham & Company analyst Mike Cikos initiated coverage on Confluent Inc (NASDAQ:CFLT) with a Buy rating and a price target of $35.…
Kenvue’s Growth Forecast: Exploring The Future Of Johnson & Johnson’s Carve-Out
RBC Capital Markets analyst Nik Modi initiated coverage on Kenvue Inc (NYSE:KVUE) with an Outperform rating and a price target of $29.…
Benzinga’s Top Ratings Upgrades, Downgrades For May 30, 2023
Upgrades Alliance Global Partners upgraded the previous rating for KNOT Offshore Partners LP (NYSE:KNOP) from Neutral to Buy.…
Benzinga’s Top Ratings Upgrades, Downgrades For May 26, 2023
Upgrades RBC Capital upgraded the previous rating for New Relic Inc (NYSE:NEWR) from Sector Perform to Outperform. For…
Bionano Genomics’ Next-Gen Platform Set to Boost Throughput by 13x: Future of Cytogenetic Analysis Underway
EF Hutton has initiated coverage of Bionano Genomics Inc (NASDAQ:BNGO) with a Buy rating and a price target of $1.75. The analyst…
Analyst’s Verdict on Legend Biotech: Doubts On Commercial Execution, Long- Term Market Share
William Blair initiated coverage on Legend Biotech Corporation (NASDAQ:LEGN) with a rating of Market Perform. The analyst says that Legend’s valuation adequately…
Analyst Sees Around 1,500% Upside For This Penny Stock Focused On Cancer
EF Hutton is assuming coverage of Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) with a Buy rating and a $6.70 price target. Sonnet has…
Benzinga’s Top Ratings Upgrades, Downgrades For May 25, 2023
Upgrades According to Susquehanna, the prior rating for Caesars Entertainment Inc (NASDAQ:CZR) was changed from Negative to Neutral.…
Zura Bio’s Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside
Raymond James initiated coverage on Zura Bio Limited (NASDAQ:ZURA) with a price target of $20 and a Strong Buy rating. Zura has…
PTC Will Profit From ServiceMax Acquisition, Analyst Predicts
BMO Capital Markets analyst Daniel Jester initiated coverage on PTC Inc (NASDAQ:PTC) at Outperform rating with a price target of $166. The…